Mergers & Acquisitions

Julia Boorstin reports on how things are changing in the digital media advertising industry with some surprising winners.

Philip Morris and Altria are in talks to merge which would be a deal that would bring back together two companies facing declining demand. Frank Holland reports.

Philip Morris International is in discussions with Altria about a possible all-stock, merger of equals, the tobacco giants announced Tuesday.

Monday marked 15 years since Google went public and as Josh Lipton reports the company has been growing throughout the years with a strong acquisition strategy.

Billionaire investor Carl Icahn believes Occidental’s acquisition of Anadarko is the worst tie-up he’s seen in his long career on Wall Street.

Pfizer will be merging with its off patent business with Mylan creating a new company that controls a number of blockbuster medicines. Meg Tirrell has more for us on this mega deal.

Pfizer, the world’s largest drugmaker, plans to divest its off-patent drug business and combine it with generic-drug maker Mylan.

With the $26 billion merger between Sprint and T-Mobile, this could bring a new era for the wireless carrier industry. Joining us to discuss this topic is Jonathan Chaplin, who’s the Managing Partner at New Street Research.

Sprint and T-Mobile’s $26 billion deal gets the Department of Justice’s approval but there are some conditions. Ylan Mui reports.

The Department of Justice has formally announced an agreement on the more than $26 billion merger between T-Mobile and Sprint.

Symantec and Broadcom have ceased deal negotiations, sources tell CNBC’s David Faber. The people familiar with the matter added that Symantec would not accept less than $28 a share.

CNBC is reporting Broadcom is in talks to acquire Symantec which is a company that makes cybersecurity software for the enterprise and consumer. Josh Lipton breaks down Broadcom’s playbook in buying companies and then building a portfolio of products.

Dish and T-Mobile are near a deal with the DOJ on a hosting agreement that would prop up Dish as a new fourth U.S. wireless competitor, sources say.

Abbvie offers to buy Allergan for $63 billion dollars as big drug makers look for new ways to grow. Meg Tirrell reports.

Pfizer makes a $10 billion deal to expand its cancer lineup and its footprint in an area as known as a precision medicine. Meg Tirrell reports.